Daniel M Altmann

InstitutionHammersmith Hospital
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 4 publications in March 2021
    All Publications
    Bar chart showing 102 publications over 20 distinct years, with a maximum of 12 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dhillon P, Altmann D, Male V. COVID-19 vaccines: what do we know so far? FEBS J. 2021 Sep; 288(17):4996-5009. PMID: 34288409.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    2. Gupta RK, Rosenheim J, Bell LC, Chandran A, Guerra-Assuncao JA, Pollara G, Whelan M, Artico J, Joy G, Kurdi H, Altmann DM, Boyton RJ, Maini MK, McKnight A, Lambourne J, Cutino-Moguel T, Manisty C, Treibel TA, Moon JC, Chain BM, Noursadeghi M. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study. Lancet Microbe. 2021 Oct; 2(10):e508-e517. PMID: 34250515.
      Citations: 1     
    3. Altmann DM, Reynolds CJ, Boyton RJ. SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition. Cell Rep Med. 2021 05 18; 2(5):100286. PMID: 34027499.
      Citations: 4     
    4. McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. NPJ Vaccines. 2021 May 13; 6(1):74. PMID: 33986272.
      Citations: 27     
    5. Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, Fontana M, Smit A, Sackville-West JE, Cutino-Moguel T, Maini MK, Chain B, Noursadeghi M, Brooks T, Semper A, Manisty C, Treibel TA, Moon JC, Valdes AM, McKnight Á, Altmann DM, Boyton R. Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science. 2021 Apr 30. PMID: 33931567.
      Citations: 39     Fields:    
    6. Boyton RJ, Altmann DM. Risk of SARS-CoV-2 reinfection after natural infection. Lancet. 2021 03 27; 397(10280):1161-1163. PMID: 33743219.
      Citations: 12     Fields:    Translation:Humans
    7. Altmann DM. Children and the return to school: how much should we worry about covid-19 and long covid? BMJ. 2021 03 15; 372:n701. PMID: 33722798.
      Citations:    Fields:    
    8. Altmann DM, Boyton RJ, Beale R. Immunity to SARS-CoV-2 variants of concern. Science. 2021 03 12; 371(6534):1103-1104. PMID: 33707254.
      Citations: 36     Fields:    Translation:Humans
    9. Manisty C, Treibel TA, Jensen M, Semper A, Joy G, Gupta RK, Cutino-Moguel T, Andiapen M, Jones J, Taylor S, Otter A, Pade C, Gibbons J, Lee J, Bacon J, Thomas S, Moon C, Jones M, Williams D, Lambourne J, Fontana M, Altmann DM, Boyton R, Maini M, McKnight A, Chain B, Noursadeghi M, Moon JC. Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection. EBioMedicine. 2021 Mar; 65:103259. PMID: 33662833.
      Citations: 18     Fields:    Translation:HumansCells
    10. Manisty C, Otter AD, Treibel TA, McKnight Á, Altmann DM, Brooks T, Noursadeghi M, Boyton RJ, Semper A, Moon JC. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021 03 20; 397(10279):1057-1058. PMID: 33640038.
      Citations: 91     Fields:    Translation:Humans
    11. Adrielle Dos Santos L, Filho PGG, Silva AMF, Santos JVG, Santos DS, Aquino MM, de Jesus RM, Almeida MLD, da Silva JS, Altmann DM, Boyton RJ, Alves Dos Santos C, Santos CNO, Alves JC, Santos IL, Magalhães LS, Belitardo EMMA, Rocha DJPG, Almeida JPP, Pacheco LGC, Aguiar ERGR, Campos GS, Sardi SI, Carvalho RH, de Jesus AR, Rezende KF, de Almeida RP. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infect. 2021 03; 82(3):399-406. PMID: 33589297.
      Citations: 26     Fields:    Translation:Humans
    12. Altmann DM, Boyton RJ. Decoding the unknowns in long covid. BMJ. 2021 02 04; 372:n132. PMID: 33541867.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    13. Reynolds CJ, Swadling L, Gibbons JM, Pade C, Jensen MP, Diniz MO, Schmidt NM, Butler DK, Amin OE, Bailey SNL, Murray SM, Pieper FP, Taylor S, Jones J, Jones M, Lee WJ, Rosenheim J, Chandran A, Joy G, Di Genova C, Temperton N, Lambourne J, Cutino-Moguel T, Andiapen M, Fontana M, Smit A, Semper A, O'Brien B, Chain B, Brooks T, Manisty C, Treibel T, Moon JC, Noursadeghi M, Altmann DM, Maini MK, McKnight Á, Boyton RJ. Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Sci Immunol. 2020 12 23; 5(54). PMID: 33361161.
      Citations: 47     Fields:    Translation:HumansCells
    14. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, Arnold D, Thomas M, Halliday A, Baum H, Rice C, Avison MB, Davidson AD, Santopaolo M, Oliver E, Goenka A, Finn A, Wooldridge L, Amulic B, Boyton RJ, Altmann DM, Butler DK, McMurray C, Stockton J, Nicholls S, Cooper C, Loman N, Cox MJ, Rivino L, Massey RC. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. Elife. 2020 12 17; 9. PMID: 33331820.
      Citations: 6     Fields:    Translation:HumansCells
    15. Altmann DM, Boyton RJ. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Sci Immunol. 2020 07 17; 5(49). PMID: 32680954.
      Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
    16. Altmann DM. Adaptive immunity to SARS-CoV-2. Oxf Open Immunol. 2020; 1(1):iqaa003. PMID: 34192266.
      Citations: 4     
    17. Altmann DM, Douek DC, Boyton RJ. What policy makers need to know about COVID-19 protective immunity. Lancet. 2020 05 16; 395(10236):1527-1529. PMID: 32353328.
      Citations: 69     Fields:    Translation:HumansCellsPHPublic Health
    Altmann's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (144)
    Explore
    _
    Co-Authors (118)
    Explore
    _
    Similar People (60)
    Explore
    _